BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 17696829)

  • 1. hNIS protein in thyroid: the iodine supply influences its expression and localization.
    Scipioni A; Ferretti E; Soda G; Tosi E; Bruno R; Costante G; Meringolo D; Arturi F; Durante C; Amorosi A; Foschini MP; Nardi F; Russo D; Filetti S
    Thyroid; 2007 Jul; 17(7):613-8. PubMed ID: 17696829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodium iodide symporter protein.
    Tonacchera M; Viacava P; Agretti P; de Marco G; Perri A; di Cosmo C; de Servi M; Miccoli P; Lippi F; Naccarato AG; Pinchera A; Chiovato L; Vitti P
    J Clin Endocrinol Metab; 2002 Jan; 87(1):352-7. PubMed ID: 11788674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of NIS expression in functioning thyroid nodules.
    Gözü HI; Yavuzer D; Kaya H; Vural S; Sargın H; Gezen C; Sargın M; Akalın S
    Kulak Burun Bogaz Ihtis Derg; 2010; 20(6):285-92. PubMed ID: 20961282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of human sodium/iodide symporter, thyroid transcription factor-1, and paired-box-protein-8 gene expression in benign thyroid diseases.
    Joba W; Spitzweg C; Schriever K; Heufelder AE
    Thyroid; 1999 May; 9(5):455-66. PubMed ID: 10365677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of correlation for sodium iodide symporter mRNA and protein expression and analysis of sodium iodide symporter promoter methylation in benign cold thyroid nodules.
    Neumann S; Schuchardt K; Reske A; Reske A; Emmrich P; Paschke R
    Thyroid; 2004 Feb; 14(2):99-111. PubMed ID: 15068624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iodide kinetics and experimental (131)I therapy in a xenotransplanted human sodium-iodide symporter-transfected human follicular thyroid carcinoma cell line.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Stokkel M; van der Heide D; Romijn JA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1247-53. PubMed ID: 11889195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the human sodium/iodide symporter (hNIS) in xenotransplanted human thyroid carcinoma.
    Smit JW; Schröder-van der Elst JP; Karperien M; Que I; Romijn JA; van der Heide D
    Exp Clin Endocrinol Diabetes; 2001; 109(1):52-5. PubMed ID: 11573141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of low sodium-iodide symporter messenger ribonucleic acid expression in malignant thyroid nodules with increased intracellular protein staining.
    Sodré AK; Rubio IG; Galrão AL; Knobel M; Tomimori EK; Alves VA; Kanamura CT; Buchpiguel CA; Watanabe T; Friguglietti CU; Kulcsar MA; Medeiros-Neto G; Camargo RY
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4141-5. PubMed ID: 18628528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycosylation of Sodium/Iodide Symporter (NIS) Regulates Its Membrane Translocation and Radioiodine Uptake.
    Chung T; Youn H; Yeom CJ; Kang KW; Chung JK
    PLoS One; 2015; 10(11):e0142984. PubMed ID: 26599396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human sodium iodide symporter gene expression in extrathyroidal tissues and cloning of its complementary deoxyribonucleic acids from salivary gland, mammary gland, and gastric mucosa.
    Spitzweg C; Joba W; Eisenmenger W; Heufelder AE
    J Clin Endocrinol Metab; 1998 May; 83(5):1746-51. PubMed ID: 9589686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors.
    Trouttet-Masson S; Selmi-Ruby S; Bernier-Valentin F; Porra V; Berger-Dutrieux N; Decaussin M; Peix JL; Perrin A; Bournaud C; Orgiazzi J; Borson-Chazot F; Franc B; Rousset B
    Am J Pathol; 2004 Jul; 165(1):25-34. PubMed ID: 15215159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Na+/I- symporter distribution in human thyroid tissues: an immunohistochemical study.
    Caillou B; Troalen F; Baudin E; Talbot M; Filetti S; Schlumberger M; Bidart JM
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4102-6. PubMed ID: 9814499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapeutic strategy for medullary thyroid cancer based on radioiodine therapy following tissue-specific sodium iodide symporter gene expression.
    Cengic N; Baker CH; Schütz M; Göke B; Morris JC; Spitzweg C
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4457-64. PubMed ID: 15941870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein.
    Eng PH; Cardona GR; Fang SL; Previti M; Alex S; Carrasco N; Chin WW; Braverman LE
    Endocrinology; 1999 Aug; 140(8):3404-10. PubMed ID: 10433193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sodium-iodide symporter protein is always present at a low expression and confined to the cell membrane in nonfunctioning nonadenomatous nodules of toxic nodular goitre.
    Tonacchera M; Viacava P; Fanelli G; Agretti P; De Marco G; De Servi M; Di Cosmo C; Chiovato L; Pinchera A; Vitti P
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):40-5. PubMed ID: 15212643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein.
    Agretti P; Dimida A; De Marco G; Ferrarini E; Rodrìguez Gonzàlez JC; Santini F; Vitti P; Pinchera A; Tonacchera M
    J Endocrinol Invest; 2011 Mar; 34(3):170-4. PubMed ID: 20479570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of sodium iodide symporter in benign and malignant human thyroid tissues.
    Lin JD; Hsueh C; Chao TC; Weng HF
    Endocr Pathol; 2001; 12(1):15-21. PubMed ID: 11478264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human sodium-iodide symporter (hNIS) gene expression is inhibited by a trans-active transcriptional repressor, NIS-repressor, containing PARP-1 in thyroid cancer cells.
    Li W; Ain KB
    Endocr Relat Cancer; 2010 Jun; 17(2):383-98. PubMed ID: 20228127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas.
    Park HJ; Kim JY; Park KY; Gong G; Hong SJ; Ahn IM
    Thyroid; 2000 Mar; 10(3):211-7. PubMed ID: 10779135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical study of Na+/I- symporter in human thyroid tissues and salivary gland tissues.
    Jhiang SM; Cho JY; Ryu KY; DeYoung BR; Smanik PA; McGaughy VR; Fischer AH; Mazzaferri EL
    Endocrinology; 1998 Oct; 139(10):4416-9. PubMed ID: 9751526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.